NCT01065207

Brief Summary

The investigators have previously described a limited group of HIV-1-infected patients, we called HIV controllers (HIC), who have been infected for more than 10 years, in whom viral replication is spontaneously controlled without any treatment. These patients are defined according to virological criteria: more than 90% of the quantifications of plasma viral load should be less than 400 RNA copies/mL. The purpose of the ANRS EP36 study was to characterize these patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 9, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

December 27, 2012

Status Verified

December 1, 2012

Enrollment Period

2 years

First QC Date

February 8, 2010

Last Update Submit

December 26, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • to allow the long-term follow-up of the HIV controllers. Epidemiological, clinical, virological, and immunological data will be collected.

Secondary Outcomes (1)

  • To understand the mechanisms involved in the control of the viral replication in HIC implies to study the patients in whom the viral control is lost and to compare them to the HIC in whom the control is preserved

Study Arms (1)

patient

NO INTERVENTION
Biological: blood test at day one

Interventions

Epidemiological, clinical, virological, and immunological data will be collected. Clinical events as neoplasia will be collected

patient

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • able to give written consent
  • who have been infected for more than 5 years
  • not treated by ARV
  • HIV positive serology
  • Covered by French Social Security

You may not qualify if:

  • Covered by French Social Security

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Le Kremlin-Bicêtre, France

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • JP Faller, MD

    CH Belfort

    PRINCIPAL INVESTIGATOR
  • Pascal Roblot, PHD

    CHU Poitiers

    PRINCIPAL INVESTIGATOR
  • Gilles Beaucaire, MD

    CHU Pointe à Pitre

    PRINCIPAL INVESTIGATOR
  • Christine Rouger, MD

    Hôpital Robert Debré REIMS

    PRINCIPAL INVESTIGATOR
  • Jean Luc Delassus, MD

    CHI Ballanger Aulnay sous Bois

    PRINCIPAL INVESTIGATOR
  • Alain Devidas, MD

    Hopital Gilles De Corbeil Corbeil

    PRINCIPAL INVESTIGATOR
  • Louis Bubertet

    Hopital St Louis Paris

    PRINCIPAL INVESTIGATOR
  • Michèle Bentata, MD

    Hopital Avicenne BOBIGNY

    PRINCIPAL INVESTIGATOR
  • Alexandra Compagnucci, MD

    Hopital Hotel Dieu Paris

    PRINCIPAL INVESTIGATOR
  • Philippe Genet, PHD

    Hopital Victore Dupouy Argenteuil

    PRINCIPAL INVESTIGATOR
  • Olivier Patey, PHD

    CHI Villeneuve St Goerges

    PRINCIPAL INVESTIGATOR
  • Marie Christine Drobacheff, MD

    CHU St Jacques Besancon

    PRINCIPAL INVESTIGATOR
  • Helder Gil, MD

    CHU Minjoz Besanson

    PRINCIPAL INVESTIGATOR
  • Eric Oksenhendler, PHD

    Hopital St Louis Paris

    PRINCIPAL INVESTIGATOR
  • Frédéric Lucht, PHD

    Hopital Bellevue St Etienne

    PRINCIPAL INVESTIGATOR
  • Michel Dupon, PHD

    Hopital Pellegrin Bordeaux

    PRINCIPAL INVESTIGATOR
  • Jean Luc Schmit, MD

    Hôpital Nord Amiens

    PRINCIPAL INVESTIGATOR
  • Daniel Sereni, PHD

    St Louis ¨Paris

    PRINCIPAL INVESTIGATOR
  • JP Viard, MD

    Hotel Dieu Paris

    PRINCIPAL INVESTIGATOR
  • JP Bru, MD

    CH Annecy

    PRINCIPAL INVESTIGATOR
  • JF Delfraissy, PHD

    Le Kremlin Bicetre

    PRINCIPAL INVESTIGATOR
  • Gilles Pichancourt

    CH Henri Duffaut Avignon

    PRINCIPAL INVESTIGATOR
  • André Pierre Blanc, MD

    CH du payx d'Aix

    PRINCIPAL INVESTIGATOR
  • Alain Lafeuillade, MD

    Hopital Chalucet Toulon

    PRINCIPAL INVESTIGATOR
  • Christophe Rapp, PHD

    Hopital Inter Armées Bégin St Mandé

    PRINCIPAL INVESTIGATOR
  • Pierre De Truchis, MD

    Hopital Raymond Pointcarré Garches

    PRINCIPAL INVESTIGATOR
  • Vincent Jeantils, MD

    Hopital Jean Verdier Bondy

    PRINCIPAL INVESTIGATOR
  • Daniel Vittecoq, PHD

    Hopital Paul Brousse Villejuif

    PRINCIPAL INVESTIGATOR
  • Gilles Pialoux, PHD

    Hopital Tenon Paris

    PRINCIPAL INVESTIGATOR
  • Olivier Bouchaud, PHD

    Hopital Avicenne Bobigny

    PRINCIPAL INVESTIGATOR
  • Francois Boué, PHD

    Hopital Antoine Béclère Clamart

    PRINCIPAL INVESTIGATOR
  • Laurence Weiss, PHD

    HEGP Paris

    PRINCIPAL INVESTIGATOR
  • Dominique Salmon Ceron, PHD

    Cochin

    PRINCIPAL INVESTIGATOR
  • Olivier Bletry, PHD

    Hopital Foch Suresnes

    PRINCIPAL INVESTIGATOR
  • Emmanuel Mortier, MD

    Louis Mourier Paris

    PRINCIPAL INVESTIGATOR
  • Alain Sobel, PHD

    Hopital Henri Mondor Créteil

    PRINCIPAL INVESTIGATOR
  • Christine Katlama, PHD

    Pitié Salpétrière Paris

    PRINCIPAL INVESTIGATOR
  • Anne Simon, MD

    Pitié Salpétrière Paris

    PRINCIPAL INVESTIGATOR
  • Pierre Marie Girard, PHD

    St Antoine Paris

    PRINCIPAL INVESTIGATOR
  • JM Molina, PHD

    St Louis Paris

    PRINCIPAL INVESTIGATOR
  • André Cabié, MD

    Hopital Pierre Zobda Quitman Fort de France

    PRINCIPAL INVESTIGATOR
  • JM Chennebault, MD

    University Hospital, Angers

    PRINCIPAL INVESTIGATOR
  • Philippe Morlat, PHD

    Hopital St André Bordeaux

    PRINCIPAL INVESTIGATOR
  • Pierre Weinbreck, PHD

    CHU Limoges

    PRINCIPAL INVESTIGATOR
  • JL Tourraine, PHD

    Hopital Edouard Herriot - Lyon

    PRINCIPAL INVESTIGATOR
  • Christian Trépo, PHD

    Hopital Hotel Dieu Lyon

    PRINCIPAL INVESTIGATOR
  • Isabelle Poizot Martin, MD

    Ste Marguerite Marseille

    PRINCIPAL INVESTIGATOR
  • Sophie Matheron, MD

    Hopital Bichat, Paris

    PRINCIPAL INVESTIGATOR
  • François Raffi, PHD

    Hopital Hotel Dieu Nantes

    PRINCIPAL INVESTIGATOR
  • Philippe Perré, MD

    CH La Roche sur Yon

    PRINCIPAL INVESTIGATOR
  • Pierre Delomonica, PHD

    Hopital l'Archet Nice

    PRINCIPAL INVESTIGATOR
  • Eric Rosenthal, PHD

    Hopital l'Archet Nice

    PRINCIPAL INVESTIGATOR
  • Christian Michelet, PHD

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR
  • David Rey, MD

    CHU Strasbourg

    PRINCIPAL INVESTIGATOR
  • JM Besnier, PHD

    Hopital Bretonneau Tours

    PRINCIPAL INVESTIGATOR
  • Bruno Marchou, PHD

    CHU Purpan (Toulouse)

    PRINCIPAL INVESTIGATOR
  • Renaud Verdon, PHD

    Hopital de la côte de Nacre Caen

    PRINCIPAL INVESTIGATOR
  • Christine Jacomet, MD

    Hopital Hotel Dieu Clermont Ferrand

    PRINCIPAL INVESTIGATOR
  • Lionel Piroth, MD

    CHU Dijon

    PRINCIPAL INVESTIGATOR
  • Pascale Leclercq, MD

    Hopital Albet Michallon Grenoble

    PRINCIPAL INVESTIGATOR
  • Yazdan Yazdanpanah, PHD

    Hopital Gustave Dron Tourcoing

    STUDY DIRECTOR
  • Thierry May, PHD

    Hopital de Brabois Nancy

    PRINCIPAL INVESTIGATOR
  • Francois Caron, PHD

    chu Rouen

    PRINCIPAL INVESTIGATOR
  • Patrick Mercié, PHD

    St André Bordeaux

    PRINCIPAL INVESTIGATOR
  • Claire Series, PHD

    Hopital Pellegrin Bordeaux

    PRINCIPAL INVESTIGATOR
  • Philippe Granier, MD

    CH Bourg en Bresse

    PRINCIPAL INVESTIGATOR
  • Marc Gatfosse, MD

    CH rené Arbeltier Coulomniers

    PRINCIPAL INVESTIGATOR
  • Patrice Poubeau, MD

    Groupe Hospitalier Sud Reunion St Pierre de la Réunion

    PRINCIPAL INVESTIGATOR
  • Agnès Uludag, MD

    Hopital Beaujon Clichy

    PRINCIPAL INVESTIGATOR
  • Philippe Arsac, MD

    CHR Orléans

    PRINCIPAL INVESTIGATOR
  • Isabelle Delacroix, MD

    CH intercommunal Créteil

    PRINCIPAL INVESTIGATOR
  • Vincent Daneluzzi, MD

    CASH Nanterre

    PRINCIPAL INVESTIGATOR
  • Elisabeth Rouveix, MD

    Hôpital Ambroise Paré Boulogne

    PRINCIPAL INVESTIGATOR
  • Goerges Diab, MD

    CH Noyon

    PRINCIPAL INVESTIGATOR
  • Geneviève Berck Wirth

    CH Mulhouse

    PRINCIPAL INVESTIGATOR
  • Philippe Romand, MD

    CHI Les hopitaux du Léman Thonon les Bains

    PRINCIPAL INVESTIGATOR
  • Laurent Blum, MD

    Hopital René Dubois Pontoise

    PRINCIPAL INVESTIGATOR
  • Christophe Michau, MD

    CH St Nazaire

    PRINCIPAL INVESTIGATOR
  • Raymond Armero, MD

    CHI Fréjus St Raphaël

    PRINCIPAL INVESTIGATOR
  • Bernard Christian, MD

    Hopital Notre Dame de Bon Secours Metz

    PRINCIPAL INVESTIGATOR
  • Philippe Muller, MD

    Hopital Beauregard Thionville

    PRINCIPAL INVESTIGATOR
  • Henri Jardel, MD

    CH Bretagne Atlantique Vannes

    PRINCIPAL INVESTIGATOR
  • Elisabeth Carbonnel, MD

    Hôpital Simone Weil Eaubonne

    PRINCIPAL INVESTIGATOR
  • Laurent Hocqueloux, MD

    Hopital La source Orléans

    PRINCIPAL INVESTIGATOR
  • Marie Odile Lemaitre, MD

    CH Juvisy sur Orge

    PRINCIPAL INVESTIGATOR
  • Patrick Philibert, MD

    Hopital Ambroise Paré Marseille

    PRINCIPAL INVESTIGATOR
  • Paul Henry Consigny, MD

    Institut Pasteur Paris

    PRINCIPAL INVESTIGATOR
  • JM Ragnaud, PHD

    Hopital Pellegrin Bordeaux

    PRINCIPAL INVESTIGATOR
  • Daniel Garipuy, MD

    Hopital Joseph Ducuing Toulouse

    PRINCIPAL INVESTIGATOR
  • Beuscart MD Claude

    CHU St Brieuc

    PRINCIPAL INVESTIGATOR
  • Leprêtre MD Annie

    Hôpital Simone Veil - Eaubonne

    PRINCIPAL INVESTIGATOR
  • Duvivier MD Claudine

    Institut Pasteur Paris

    PRINCIPAL INVESTIGATOR
  • Garipuy MD Daniel

    Hôpital Joseph Ducuing Toulouse

    PRINCIPAL INVESTIGATOR
  • Aumaitre MD Hugues

    Centre hospitalier de Perpignan

    PRINCIPAL INVESTIGATOR
  • Rami MD Agathe

    Lariboisière Paris

    PRINCIPAL INVESTIGATOR
  • De Lavassière MD Marc

    CH Général Montauban

    PRINCIPAL INVESTIGATOR
  • Miailhes MD Patrick

    Hôpital Croix Rousse Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2010

First Posted

February 9, 2010

Study Start

March 1, 2009

Primary Completion

March 1, 2011

Study Completion

March 1, 2012

Last Updated

December 27, 2012

Record last verified: 2012-12

Locations